Covid19 Primer

Title	Date	Topic	Relevance
Beneficial effects of Chinese patent medicine ZhengQi tablet on treating the mild COVID-19 Bowu Chen et al in None Source crossref_works_2020_03_25	Feb 07, 2023	Placebo-controlled & Randomized	0.4
A single center, double blind, randomized, placebo controlled trial of anakinra in adult patients with features of Cytokine Storm Syndrome in COVID-19 Randy Q Cron et al in journal of immunology (5.422) Source crossref_works_2020_03_25	Feb 07, 2023	Placebo-controlled & Randomized	0.3
Promoting Hand Hygiene During the COVID-19 Pandemic: Parallel Randomized Trial for the Optimization of the Soapp App Dario Baretta et al in jmir mhealth and uhealth (4.773) Source crossref_works_2020_03_25	Feb 03, 2023	Placebo-controlled & Randomized	0.2
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: randomised, active-controlled, observer-blinded, phase 3 trial Joon Young Song et al in medRxiv : the preprint server for health sciences Source crossref_works_2020_03_25 Preprint	Feb 02, 2023	Placebo-controlled & Randomized	0.4
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial Aleksandr V. Kudriavtsev et al in vaccines (4.422) Source crossref_works_2020_03_25	Feb 01, 2023	Placebo-controlled & Randomized	0.4
Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial Emily Oulousian et al in jmir research protocols Source crossref_works_2020_03_25	Jan 31, 2023	Placebo-controlled & Randomized	0.5
Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi Nawal Al Kaabi et al in vaccines (4.422) Source crossref_works_2020_03_25	Jan 30, 2023	Placebo-controlled & Randomized	0.4
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial Huijie Bian et al in signal transduction and targeted therapy (18.187) Source crossref_works_2020_03_25	Jan 30, 2023	Placebo-controlled & Randomized	0.2
A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection Amit Singla et al in plos one (3.24) Source crossref_works_2020_03_25	Jan 30, 2023	Placebo-controlled & Randomized	0.8
Randomized Controlled Trial Evaluating the Benefit of a Novel Clinical Decision Support System for the Management of COVID-19 Patients in Home Quarantine: A Study Protocol Irene Alcoceba-Herrero et al in international journal of environmental research and public health (3.39) Source crossref_works_2020_03_25	Jan 28, 2023	Placebo-controlled & Randomized	0.2